BDP® 650/665 alkyne

Cat. # Quantity Price Lead time
A84B0 1 mg $125 in stock
B84B0 5 mg $260 in stock
C84B0 10 mg $325 in stock
D84B0 25 mg $510 in stock
E84B0 50 mg $895 in stock
F84B0 100 mg $1490 in stock
Found better price? Let us know and we will propose the way forward!

BDP 650/665 alkyne is a red-emitting BDP dye derivative carrying a terminal alkyne group for a copper-catalyzed conjugation with azides. Absorption and emission spectra of BDP 650/665 are designed to fit Cy5-channel of various instruments.

Absorption and emission spectra of BDP 650/665

Absorption and emission spectra of BDP 650/665

Customers also purchased with this product

Cholesterol-PEG4-azide

Cholesterol derivative with azide group for сlick chemistry conjugation.

BDP® 630/650 alkyne

Alkyne dye for copper-catalyzed click chemistry, containing borondipyrromethene fluorophore BDP 630/650 for the red channel.

EdU (5-Ethynyl-2'-deoxyuridine)

EdU is a nucleoside that is incorporated into replicated DNA by cellular enzymes. After it, DNA contained in the cells can be developed by click chemistry reaction with fluorescent dye azides to reveal cell proliferation.

General properties

Appearance: dark colored solid
Molecular weight: 470.28
CAS number: 2006345-40-8
Molecular formula: C26H21N4BF2O2
Solubility: soluble in DMF, DMSO
Quality control: NMR 1H, HPLC-MS (95%)
Storage conditions: Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate.
MSDS: Download
Product specifications

Spectral properties

Excitation/absorption maximum, nm: 649
ε, L⋅mol−1⋅cm−1: 94000
Emission maximum, nm: 667
Fluorescence quantum yield: 0.52
CF260: 0.04
CF280: 0.04

Product citations

  1. Iacobazzi, R.M.; Arduino, I.; Di Fonte, R.; Lopedota, A.A.; Serratì, S.; Racaniello, G.; Bruno, V.; Laquintana, V.; Lee, B.-C.; Silvestris, N.; Leonetti, F.; Denora, N.; Porcelli, L.; Azzariti, A. Microfluidic-Assisted Preparation of Targeted pH-Responsive Polymeric Micelles Improves Gemcitabine Effectiveness in PDAC: In Vitro Insights. Cancers, 2022, 14(1), 5. doi: 10.3390/cancers14010005
Your item has been added. View your cart or proceed to checkout
The count of items is incorrect.